News from endo international plc A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages

Latest

24 Jan, 2020, 22:00 GMT Endo to Announce Fourth-Quarter and Full-Year 2019 Financial Results

Endo International plc (NASDAQ: ENDP) will announce its fourth-quarter and full-year 2019 financial results on February 26, 2020 and members of its...


10 Jan, 2020, 17:04 GMT Endo Settles Opioid Investigation with State of Oklahoma for $8.75 million

Endo International plc (NASDAQ: ENDP) today announced that its subsidiaries Endo Pharmaceuticals Inc. and Par Pharmaceutical, Inc. (collectively, the ...


17 Dec, 2019, 22:00 GMT Endo to Participate at J.P. Morgan Healthcare Conference

Endo International plc (NASDAQ: ENDP) announced today that members of management will present at the J.P. Morgan Healthcare Conference in San...


10 Dec, 2019, 13:07 GMT Endo Launches Generic Version of Afinitor® (everolimus) Tablets in the United States

Endo International plc (NASDAQ: ENDP) today announced that one of its operating companies, Par Pharmaceutical (Par), has received approval for and...


22 Nov, 2019, 22:00 GMT Endo to Participate at Bank of America Merrill Lynch Leveraged Finance Conference

Endo International plc (NASDAQ: ENDP) announced today that members of management will participate in a fireside chat at the Bank of America Merrill...


19 Nov, 2019, 21:10 GMT Endo Announces FDA's Acceptance of Original Biologics License Application (BLA) for Collagenase Clostridium Histolyticum (CCH) in Patients with Cellulite

Endo International plc (NASDAQ: ENDP) announced today that the U.S. Food and Drug Administration (FDA) has accepted for review the original Biologics ...


04 Nov, 2019, 21:15 GMT Endo Implements CEO Succession Plan

Endo International plc (NASDAQ: ENDP) today announced that Paul V. Campanelli, President and Chief Executive Officer has notified the Board of...


04 Nov, 2019, 21:15 GMT Endo Reports Third-Quarter 2019 Financial Results

Endo International plc (NASDAQ: ENDP) today reported third-quarter 2019 financial results, including: Revenues of $729 million decreased 2% compared...


28 Oct, 2019, 11:30 GMT Endo Aesthetics Launches New Campaign Elevating Artistry Through Scientific Innovation

Endo International plc (NASDAQ: ENDP) announced that Endo Aesthetics launched a "Redefining Scientific Artistry" campaign at the Annual Meeting of...


25 Oct, 2019, 12:30 BST Endo Presents New XIAFLEX® (collagenase clostridium histolyticum) Data at the 2019 Fall Meeting of the Sexual Medicine Society of North America (SMSNA)

Endo International plc (NASDAQ: ENDP) today announced that five new studies of XIAFLEX® (collagenase clostridium histolyticum) for the treatment of...


24 Oct, 2019, 12:30 BST Endo Presents Data on the Use of a Standing MRI for the Evaluation of Cellulite at the American Society for Dermatologic Surgery (ASDS) Annual Meeting

Endo International plc (NASDAQ: ENDP) today announced that it will present data on the use of a standing MRI as compared to prone MRI for the...


02 Oct, 2019, 22:00 BST Endo to Announce Third-Quarter 2019 Financial Results

Endo International plc (NASDAQ: ENDP) will announce its third-quarter 2019 financial results on November 5, 2019 and members of its senior management ...


30 Sep, 2019, 12:30 BST Endo Announces Successful Culmination of Litigation Regarding FDA Compounding Policy

Endo International plc ("Endo") (NASDAQ: ENDP) today announced the successful culmination of two litigation matters before the U.S. District Court...


06 Sep, 2019, 15:29 BST Endo Announces Submission of Biologics License Application to FDA for Collagenase Clostridium Histolyticum (CCH) in Patients with Cellulite

Endo International plc (NASDAQ: ENDP) announced today that the Company has submitted a Biologics License Application (BLA) to the U.S. Food and Drug...


05 Sep, 2019, 12:00 BST Endo to Present New XIAFLEX® (collagenase clostridium histolyticum) Data at the 2019 American Society for Surgery of the Hand's (ASSH) Annual Meeting

Endo International plc (NASDAQ: ENDP) today announced that four new studies of XIAFLEX® (collagenase clostridium histolyticum), including real-world...


04 Sep, 2019, 12:30 BST Endo Announces Approval of First Generic Orfadin® in U.S.

Endo International plc (NASDAQ: ENDP) today announced that Novitium Pharma, LLC, a partner of Endo's subsidiary Endo Ventures Limited, received...


03 Sep, 2019, 11:30 BST Endo Launches Authorized Generic Version of Noxafil® (posaconazole) Delayed-release Tablets in the United States

Endo International plc (NASDAQ: ENDP) announced today that one of its operating companies, Par Pharmaceutical (Par), has begun shipping an authorized ...


20 Aug, 2019, 14:33 BST Endo Announces Settlement in Principle to Resolve "Track 1" Opioid Cases

In light of recent media coverage and inquiries, Endo International plc (NASDAQ: ENDP) today announced that its subsidiaries Endo Pharmaceuticals Inc....


02 Aug, 2019, 11:00 BST Endo Applauds U.S. District Court Decision that Vasopressin Cannot be Used for Compounding by Outsourcing Facilities

Endo International plc ("Endo") (NASDAQ: ENDP) today applauded the U.S. District Court for the District of Columbia's decision supporting the Food...


01 Aug, 2019, 12:30 BST Endo Appoints Domenico Ciarico as Executive Vice President and Chief Commercial Officer, Sterile and Generics

Endo International plc (NASDAQ: ENDP) announced today the appointment of Domenic Ciarico as Executive Vice President and Chief Commercial Officer,...


31 Jul, 2019, 13:00 BST Helsinn and Endo Announce Agreement for Paladin Labs Inc. to Commercialize Pracinostat in Canada

Endo International plc (NASDAQ: ENDP) and Helsinn, a Swiss pharmaceutical group focused on building quality cancer care products, are pleased to...


06 Jun, 2019, 12:30 BST Nationally Recognized Urologist and Author, Aaron Spitz, MD, Teams Up with Endo Pharmaceuticals' Ask About the Curve Campaign to Encourage Men to Get "In Touch" With Their Anatomy This Men's Health Month

Ask About the Curve raises awareness of Peyronie's disease, a men's health condition that may affect about 1 in 10 men and leads to a pronounced...


17 May, 2019, 12:00 BST Phase 3 Data of Collagenase Clostridium Histolyticum for the Investigational Treatment of Cellulite to Be Presented at The Aesthetic Meeting 2019

Endo International plc (NASDAQ: ENDP) today announced that clinical data from a Phase 3 investigational study of collagenase clostridium histolyticum ...


15 May, 2019, 22:00 BST Endo to Participate at RBC Healthcare Conference

Endo International plc (NASDAQ: ENDP) announced today that members of management will participate in a fireside chat at the RBC Annual Healthcare...


09 May, 2019, 11:30 BST Endo Reports First-Quarter 2019 Financial Results

First-quarter 2019 revenues increased 3 percent to $720 million compared to first-quarter 2018 revenues of $701 million First-quarter 2019 Sterile...